Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
Sec Filings Insider Trading - Protalix BioTherapeutics Inc. (PLX)
Select Time period:       google icon google     yahoo icon yahoo!
Send this page to:   blogger icon Blog    digg icon Digg    reddit icon Reddit    facebook icon Facebook    stumble icon Stumble    delicious icon del.icio.us
Enter Stock Ticker Symbol or Cik: SEC Cik Lookup Cik Lookup...
Search By Company or Insider Name: Powered by Google button
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch ==>> What is insider trading>>
PLX Insider Trading Transactions for Protalix BioTherapeutics Inc.
Protalix BioTherapeutics Inc: Insider Trading and Stock Options
Common stock purchase or sale:
Transaction
& Date		 Reported
Date		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Ownership		 Filing
2013-03-12
Sale		 2013-03-14
7:00 pm		 Protalix BioTherapeutics, Inc. PLX Akirov Alfred
(Director)		 10,000 $5.7 $57,000 5,027,713
(Indirect)		 View
2013-03-08-
-2013-03-11
Sale		 2013-03-12
6:30 pm		 Protalix BioTherapeutics, Inc. PLX Akirov Alfred
(Director)		 35,198 $5.79 $203,805 5,037,711
(Indirect)		 View
2013-03-06-
-2013-03-07
Sale		 2013-03-08
5:04 pm		 Protalix BioTherapeutics, Inc. PLX Akirov Alfred
(Director)		 13,135 $5.708 $74,970 5,072,911
(Indirect)		 View
2012-05-02
Sale		 2012-05-04
5:14 pm		 Protalix BioTherapeutics, Inc. PLX Shaaltiel Yoseph
(Executive VP, R&D
Director)		 300,000 $7.13 $2,139,000 463,754
(Direct)		 View
2012-05-02
Sale		 2012-05-04
5:13 pm		 Protalix BioTherapeutics, Inc. PLX Maimon Yossi
(VP, Chief Financial Officer)		 125,964 $7.13 $898,123 0
(Indirect)		 View
2012-05-02
Sale		 2012-05-04
5:11 pm		 Protalix BioTherapeutics, Inc. PLX Aviezer David
(President & CEO
Director)		 450,000 $7.13 $3,208,500 0
(Indirect)		 View
2012-05-02
Sale		 2012-05-04
5:10 pm		 Protalix BioTherapeutics, Inc. PLX Almon Einat Brill
(SVP, Product Development)		 166,848 $7.13 $1,189,626 0
(Indirect)		 View
Other transactions:
Transaction
& Date		 Reported
Date		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Ownership		 Filing
2012-07-16
Option Award		 2012-07-18
4:40 pm		 Protalix BioTherapeutics, Inc. PLX Lauterbach Sandra Leigh
(VP, Sales & Commercial Affairs)		 20,000 $0 $0 20,000
(Indirect)		 View
2012-07-16
Option Award		 2012-07-18
4:38 pm		 Protalix BioTherapeutics, Inc. PLX Palash Tzvi
(Chief Operating Officer)		 102,000 $0 $0 102,000
(Indirect)		 View
2012-07-16
Option Award		 2012-07-18
4:37 pm		 Protalix BioTherapeutics, Inc. PLX Maimon Yossi
(Vice President & CFO)		 185,000 $0 $0 185,000
(Indirect)		 View
2012-07-16
Option Award		 2012-07-18
4:34 pm		 Protalix BioTherapeutics, Inc. PLX Almon Einat Brill
(SVP, Product Development)		 185,000 $0 $0 185,000
(Indirect)		 View
2012-07-16
Option Award		 2012-07-18
4:32 pm		 Protalix BioTherapeutics, Inc. PLX Shaaltiel Yoseph
(Executive VP, R&D
Director)		 210,000 $0 $0 210,000
(Indirect)		 View
2012-07-16
Option Award		 2012-07-18
4:31 pm		 Protalix BioTherapeutics, Inc. PLX Aviezer David
(President & CEO
Director)		 418,000 $0 $0 418,000
(Indirect)		 View
2012-05-02
Exercise		 2012-05-04
5:13 pm		 Protalix BioTherapeutics, Inc. PLX Maimon Yossi
(VP, Chief Financial Officer)		 125,964 $1.638 $206,337 125,964
(Indirect)		 View
2012-05-02
Exercise		 2012-05-04
5:11 pm		 Protalix BioTherapeutics, Inc. PLX Aviezer David
(President & CEO
Director)		 450,000 $0.3543 $159,421 450,000
(Indirect)		 View
2012-05-02
Exercise		 2012-05-04
5:10 pm		 Protalix BioTherapeutics, Inc. PLX Almon Einat Brill
(SVP, Product Development)		 166,848 $1.475 $246,076 166,848
(Indirect)		 View
Stock options: Exercise, Award, Grant, Conversion
Transaction
& Date		 Reported
Date		 Exercisable
Expiration		 Company Symbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Ownership		 Filing
2012-05-02
Exercise		 2012-05-04
5:13 pm		 N/A
2016-09-19		 Protalix BioTherapeutics, Inc. PLX Maimon Yossi
(VP, Chief Financial Officer)		 75,964 $0.972 0
(Direct)		 View
2012-05-02
Exercise		 2012-05-04
5:13 pm		 N/A
2019-02-25		 Protalix BioTherapeutics, Inc. PLX Maimon Yossi
(VP, Chief Financial Officer)		 50,000 $2.65 0
(Direct)		 View
2012-05-02
Exercise		 2012-05-04
5:11 pm		 N/A
2013-12-08		 Protalix BioTherapeutics, Inc. PLX Aviezer David
(President & CEO
Director)		 326,267 $0.12 0
(Direct)		 View
2012-05-02
Exercise		 2012-05-04
5:11 pm		 N/A
2016-09-10		 Protalix BioTherapeutics, Inc. PLX Aviezer David
(President & CEO
Director)		 123,733 $0.972 853,563
(Direct)		 View
2012-05-02
Exercise		 2012-05-04
5:10 pm		 N/A
2016-08-13		 Protalix BioTherapeutics, Inc. PLX Almon Einat Brill
(SVP, Product Development)		 116,848 $0.972 0
(Direct)		 View
2012-05-02
Exercise		 2012-05-04
5:10 pm		 N/A
2019-02-25		 Protalix BioTherapeutics, Inc. PLX Almon Einat Brill
(SVP, Product Development)		 50,000 $2.65 0
(Direct)		 View